Cochlear Limited (OC5)

Overview

Cochlear Limited, established in 1981 and headquartered in Sydney, Australia, is a global leader in providing implantable hearing solutions. It is dedicated to helping children and adults worldwide to overcome hearing loss through innovative technologies. The company takes pride in its extensive history of advancing the field of auditory health, offering a range of products that enhance the ability to hear and communicate effectively.

Products and Services

• Cochlear Implant Systems: These systems are designed to mimic natural hearing and provide a solution for individuals with severe to profound nerve deafness. They work by directly stimulating the cochlea's nerve fibers, bypassing damaged parts of the ear.
• Sound Processor Upgrades: Cochlear offers advanced sound processors that are compatible with its implant systems. These upgrades are designed to improve sound quality, offer new features, and ensure users have access to the latest technology in hearing solutions.
• Bone Conduction Systems: For individuals with conductive hearing loss, mixed hearing loss, or single-sided deafness, Cochlear's bone conduction systems transmit sound through the skull bone directly to the inner ear. This innovative approach offers an alternative to traditional hearing aids by providing clearer sound quality under various conditions.
• Accessories: To enhance the user experience, Cochlear provides a wide range of accessories for its devices. These include wireless streaming devices, waterproof cases, and remote controls, among others. Each accessory is designed to make daily use more convenient and to help users customize their hearing experience.
• Beyond the core offerings, Cochlear continuously innovates to include new products and services that address the broader needs of the hearing-impaired community. This commitment to innovation ensures that users have access to the most advanced solutions available.